Navigation Links
Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced
Date:4/17/2008

Center, Morgan Stanley Children's Hospital of New York-Presbyterian, New York- Presbyterian Hospital/Westchester Division and New York-Presbyterian Hospital/The Allen Pavilion. Weill Cornell Medical College is the first U.S. medical college to offer a medical degree overseas and maintains a strong global presence in Austria, Brazil, Haiti, Tanzania, Turkey and Qatar. For more information, visit http://www.nyp.org and http://www.med.cornell.edu.

About Baxter

Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other indications. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

This release includes forward-looking statements concerning GAMMAGARD S/D and GAMMAGARD LIQUID [Immune Globulin Intravenous (IGIV)] relating to clinical trials as well as potential future uses of the products. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: continued review of Phase II data and the limited number of patients studied to date; additional regulatory and other steps required prior to the initiation of the larger Phase III study described in the release; and other risks identified in Baxter's most recent filing on Form 10-K and other Securities and Exchange Commission filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.


'/>"/>
SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015  Array BioPharma Inc. (Nasdaq: ... Executive Officer, Ron Squarer , will present ... New York City. The public is welcome to participate ... Array BioPharma website.Event: Jefferies 2015 Global Healthcare ConferencePresenter:Ron ... Eastern Time Webcast: www.arraybiopharma.com  About Array BioPharma ...
(Date:5/26/2015)... May 26, 2015 Sanomedics, Inc. (OTC: SIMH) ... has expanded into the fast growing behavioral health sector ... is a developmental stage, Software as a Services (SaaS) ... addiction treatment service and care centers. ... to enter the nascent behavioral health sector where the ...
(Date:5/26/2015)... , May 26, 2015 Boston Scientific Corporation ... Goldman Sachs 36 th Annual Global Healthcare Conference on ... Dan Brennan , executive vice president ... president, Investor Relations, will participate in a 35-minute question and ... at approximately 10 a.m. PT. A live webcast ...
Breaking Medicine Technology:Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 2Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 3Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference 2
... of once-daily TMC278 in ... treatment-naive adults with HIV-1 -, ... from Tibotec,Pharmaceuticals Ltd. provides additional information on the safety ... inhibitor (NNRTI), as part of HIV,combination therapy in treatment-naive ...
... CAMBRIDGE, Mass., Aug. 5 Tolerx, Inc., a,biopharmaceutical ... novel,therapies for the treatment of immune-mediated diseases, announced ... version of TRX1,MTRX1011A, an anti-CD4 monoclonal antibody, into ... patients. The clinical trial is evaluating the,safety and ...
Cached Medicine Technology:Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
(Date:5/26/2015)... (PRWEB) May 26, 2015 It was ... community foundation in Colorado. On Wednesday, May 13, The ... in a new era of community-based giving with its ... “Our Future in the Making,” the event celebrated the ... Denver Foundation to mobilize resources for good. , “If ...
(Date:5/26/2015)... Synthetic cannabinoids attempt to mimic ... published by International Business Times on ... and black mamba) causes unpredictable medical and psychiatric ... make it nearly impossible for medical doctors to ... substance due to the frequency in which the ...
(Date:5/26/2015)... Norcross, GA (PRWEB) May 26, 2015 ... partnered with Airbus Defence and Space in a new ... data and software for use in the development of ... Hexagon Content Program, this partnership combines optical satellite data ... offerings. Intended to tear down the walls between geospatial ...
(Date:5/26/2015)... NY (PRWEB) May 26, 2015 Award-winning travel ... a good cause. "The photography show will connect viewers to ... their lives.” For the last five years, Raul has traveled ... convey the notion that we are not bounded by our ... language spoken in Raul’s native country, Bolivia. The photo gallery ...
(Date:5/26/2015)... 2015 On June 4, 2015, ... online broadcast at 6:00pm PST/9:00 pm EST. This ... Alice Branton welcomes the public to attend and invite ... profound knowledge, transformation and enlightenment. The webinar is ... previous knowledge, experience or other prerequisites are required. , ...
Breaking Medicine News(10 mins):Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 2Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 3Health News:A Photographer & Two Educational Organiazations Join to Make a Difference in Our Youth 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 3
... from eating fish to krill (shrimp-like marine invertebrate animals) ... and whales, ancient eggshell fragments reveal. ... Carolina in Wilmington, and William Patterson of the University ... removed krill-eating predators, the penguins exploited the resulting shrimp ...
... time, researchers have shown that plant growth is regulated ... ,Using time-lapse photography, post-doctoral researcher Kazunari Nozue, ... the University of Lausanne, Switzerland, found that the shoots ... a day. They claimed that the timing of that ...
... first after restoring the fertility of a woman made ... ,The gynaecologist, Jacques Donnez, said he had successfully ... at the Cliniques Universitaires Saint-Luc in Brussels. ... graft, the patient continues to menstruate regularly. Her ovarian ...
... the stone that kills two vices. ,United States FDA-approved smoking ... handed out to alcoholics as well . , The ... used quite successfully by smokers , was tested to reveal the ... ,Says Selena Bartlett, a University of California, San Francisco ...
... ESMO Conference Lugano this week show that the drug, ... a marker of cancer activity, and shrank tumors in ... also in patients who had previously been treated with ... have continued to grow despite medical or surgical castration, ...
... in the July issue of the journal Cancer Cell, ... in development of acute promyelocytic leukemia (APL) and identifies ... its variant forms. ,Results from two new ... events that cause a deadly type of leukemia.,APL is ...
Cached Medicine News:Health News:Penguins Altered Diet When Humans Began Hunting Whales and Seals 2Health News:Two In One Drug For Smokers And Drinkers 2Health News:Hormone Inhibitor in Prostate Cancer Treatment 2Health News:Insights into Acute Promyelocytic Leukemia 2Health News:Insights into Acute Promyelocytic Leukemia 3
Non-reflective black anodized aluminum. Selection of five pin hole sizes (0.8 mm to 1.5 mm). Overall length: 4.0 inches....
4 mm x 4 mm downward biting jaws, curved right, length of shaft 115 mm, overall length 9.3 inches....
Right side cutting....
20 mm. Plastic, methylmethacrylate. Supplied sterile....
Medicine Products: